Variants of triggering receptor expressed on myeloid cells 2 (TREM2) are associated with an increased incidence of Alzheimer’s disease, as well as other neurodegenerative disorders. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.